Literature DB >> 12044622

ATP can enhance the proton-induced CGRP release through P2Y receptors and secondary PGE(2) release in isolated rat dura mater.

K Zimmermann1, P W Reeh, B Averbeck.   

Abstract

Trigeminal afferent neurons express ionotropic P2X receptors for extracellular ATP which are known to be sensitive to low interstitial pH. Both conditions - ATP release and tissue acidosis - may occur in the dura following the ischemia phase of migraine attacks. Aim of this study was to investigate whether and how ATP and protons may cooperate in exciting meningeal afferents. After removal of the cerebral hemispheres hemisected scull cavities of adult Wistar rats were used as organ bath of their own lining, the dura mater. The dura was chemically stimulated and the amounts of immunoreactive calcitonin gene-related peptide (iCGRP) and prostaglandin E(2) (PGE(2)) released into incubation fluid were measured using enzyme immunoassays. Stimulation with ATP (10(-4) and 10(-3)M) augmented iPGE(2) release dose-dependently whereas iCGRP secretion was minimally enhanced only if the dura had previously been depleted of extracellular ATP using hexokinase. Acid buffer solutions (pH 5.9 and 5.4) resulted in pH-dependent increase of iCGRP release but reduced iPGE(2) release. Purines (ATP 10(-3)>UTP 10(-4)M>ATP 10(-4)M) and PGE(2) (10(-5)M) were found to facilitate the proton-induced increase in iCGRP release. The proton-reduction of PGE(2) release was overcome by adding ATP (10(-3)M). S(+)-flurbiprofen (10(-6)M) suppressed both the basal and stimulated iPGE(2) release and prevented the ATP(10(-4)M)-induced facilitation of the proton response. The facilitating effect of ATP was also blocked under suramin, a non-selective P2 antagonist, and under reactive blue, an non-selective P2Y-antagonist, but not under pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid, a P2X-antagonist. The present results provide evidence that ATP has poor, if at all, direct excitatory effects on CGRP-containing trigeminal nerve endings in the isolated dura and its facilitatory action seems to depend on G-protein coupled P2Y receptors and secondary PGE(2) release. The UTP effect and the antagonist profile is indicative for the P2Y(2) receptor subtype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044622     DOI: 10.1016/S0304-3959(02)00027-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  12 in total

Review 1.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  Functions of neuronal P2Y receptors.

Authors:  Simon Hussl; Stefan Boehm
Journal:  Pflugers Arch       Date:  2006-05-10       Impact factor: 3.657

Review 3.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

Review 4.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

5.  ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa.

Authors:  Jie Ma; Annamaria Altomare; Florian Rieder; Jose Behar; Piero Biancani; Karen M Harnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-09-29       Impact factor: 4.052

6.  Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture.

Authors:  Li Lei; Xingyun Yuan; Shaolan Wang; Fujun Zhang; Yan Han; Qilan Ning; Guogang Luo; Shemin Lu
Journal:  J Mol Neurosci       Date:  2012-04-20       Impact factor: 3.444

Review 7.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

8.  EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.

Authors:  Richard J Davis; Colin E Murdoch; Mozam Ali; Stuart Purbrick; Rivka Ravid; Gordon S Baxter; Nick Tilford; Robert L G Sheldrick; Kenneth L Clark; Robert A Coleman
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

9.  BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

Authors:  K A Maubach; R J Davis; D E Clark; G Fenton; P M Lockey; K L Clark; A W Oxford; R M Hagan; C Routledge; R A Coleman
Journal:  Br J Pharmacol       Date:  2009-01-19       Impact factor: 8.739

10.  Acid-evoked Ca2+ signalling in rat sensory neurones: effects of anoxia and aglycaemia.

Authors:  Michael Henrich; Keith J Buckler
Journal:  Pflugers Arch       Date:  2009-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.